Jimi Olaghere has lived with sickle cell disease his whole life—experiencing chronic pain, organ damage, and hopelessness. As a patient enrolled in a clinical trial for Vertex’s new exa-cel treatment, he was among the first to experience CRISPR’s transformative effects. It changed his life.